nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0353	0.052	CbGbCtD
Hydromorphone—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0332	0.0489	CbGbCtD
Hydromorphone—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0332	0.0489	CbGbCtD
Hydromorphone—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0323	0.0475	CbGbCtD
Hydromorphone—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0303	0.0447	CbGbCtD
Hydromorphone—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0303	0.0447	CbGbCtD
Hydromorphone—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.03	0.0442	CbGbCtD
Hydromorphone—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.03	0.0442	CbGbCtD
Hydromorphone—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0274	0.0404	CbGbCtD
Hydromorphone—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0274	0.0404	CbGbCtD
Hydromorphone—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0259	0.0382	CbGbCtD
Hydromorphone—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0251	0.037	CbGbCtD
Hydromorphone—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0237	0.0349	CbGbCtD
Hydromorphone—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.023	0.0339	CbGbCtD
Hydromorphone—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0227	0.0335	CbGbCtD
Hydromorphone—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0227	0.0335	CbGbCtD
Hydromorphone—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0218	0.0321	CbGbCtD
Hydromorphone—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0208	0.0306	CbGbCtD
Hydromorphone—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0208	0.0306	CbGbCtD
Hydromorphone—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0205	0.0302	CbGbCtD
Hydromorphone—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0193	0.0284	CbGbCtD
Hydromorphone—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0193	0.0284	CbGbCtD
Hydromorphone—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0174	0.0257	CbGbCtD
Hydromorphone—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0174	0.0257	CbGbCtD
Hydromorphone—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0151	0.0222	CbGbCtD
Hydromorphone—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0146	0.0215	CbGbCtD
Hydromorphone—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0132	0.0195	CbGbCtD
Hydromorphone—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0132	0.0195	CbGbCtD
Hydromorphone—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0127	0.0187	CbGbCtD
Hydromorphone—OPRM1—nerve—acquired immunodeficiency syndrome	0.00278	0.116	CbGeAlD
Hydromorphone—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.0015	0.0623	CbGeAlD
Hydromorphone—PTGS1—endothelium—acquired immunodeficiency syndrome	0.00115	0.048	CbGeAlD
Hydromorphone—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00112	0.0467	CbGeAlD
Hydromorphone—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.00103	0.0426	CbGeAlD
Hydromorphone—OPRD1—nervous system—acquired immunodeficiency syndrome	0.000916	0.0381	CbGeAlD
Hydromorphone—OPRD1—central nervous system—acquired immunodeficiency syndrome	0.000882	0.0367	CbGeAlD
Hydromorphone—OPRK1—nervous system—acquired immunodeficiency syndrome	0.000879	0.0365	CbGeAlD
Hydromorphone—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000856	0.0356	CbGeAlD
Hydromorphone—OPRK1—central nervous system—acquired immunodeficiency syndrome	0.000846	0.0352	CbGeAlD
Hydromorphone—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000842	0.035	CbGeAlD
Hydromorphone—OPRD1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0008	0.0269	CbGpPWpGaD
Hydromorphone—OPRM1—blood—acquired immunodeficiency syndrome	0.00077	0.032	CbGeAlD
Hydromorphone—OPRM1—spinal cord—acquired immunodeficiency syndrome	0.000742	0.0308	CbGeAlD
Hydromorphone—OPRK1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000702	0.0236	CbGpPWpGaD
Hydromorphone—OPRD1—brain—acquired immunodeficiency syndrome	0.0007	0.0291	CbGeAlD
Hydromorphone—OPRK1—brain—acquired immunodeficiency syndrome	0.000672	0.0279	CbGeAlD
Hydromorphone—OPRM1—nervous system—acquired immunodeficiency syndrome	0.000625	0.026	CbGeAlD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000621	0.0209	CbGpPWpGaD
Hydromorphone—OPRM1—central nervous system—acquired immunodeficiency syndrome	0.000602	0.025	CbGeAlD
Hydromorphone—OPRM1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000593	0.0199	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000545	0.0183	CbGpPWpGaD
Hydromorphone—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000493	0.0205	CbGeAlD
Hydromorphone—OPRM1—brain—acquired immunodeficiency syndrome	0.000478	0.0199	CbGeAlD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.00046	0.0155	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000447	0.015	CbGpPWpGaD
Hydromorphone—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000432	0.018	CbGeAlD
Hydromorphone—OPRD1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00042	0.0141	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000417	0.014	CbGpPWpGaD
Hydromorphone—CYP2C9—blood—acquired immunodeficiency syndrome	0.000411	0.0171	CbGeAlD
Hydromorphone—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000394	0.0164	CbGeAlD
Hydromorphone—OPRK1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000392	0.0132	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000376	0.0127	CbGpPWpGaD
Hydromorphone—PTGS1—blood—acquired immunodeficiency syndrome	0.000376	0.0156	CbGeAlD
Hydromorphone—OPRK1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000369	0.0124	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000365	0.0123	CbGpPWpGaD
Hydromorphone—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000362	0.015	CbGeAlD
Hydromorphone—PTGS1—vagina—acquired immunodeficiency syndrome	0.000348	0.0145	CbGeAlD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.00034	0.0114	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000331	0.0111	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.00033	0.0111	CbGpPWpGaD
Hydromorphone—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000329	0.0137	CbGeAlD
Hydromorphone—PTGS1—lung—acquired immunodeficiency syndrome	0.000329	0.0137	CbGeAlD
Hydromorphone—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000324	0.0135	CbGeAlD
Hydromorphone—OPRD1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000317	0.0107	CbGpPWpGaD
Hydromorphone—CYP3A4—blood—acquired immunodeficiency syndrome	0.000314	0.013	CbGeAlD
Hydromorphone—OPRM1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.000312	0.0105	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000309	0.0104	CbGpPWpGaD
Hydromorphone—CYP2D6—blood—acquired immunodeficiency syndrome	0.000309	0.0128	CbGeAlD
Hydromorphone—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000305	0.0127	CbGeAlD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000298	0.01	CbGpPWpGaD
Hydromorphone—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000293	0.0122	CbGeAlD
Hydromorphone—OPRD1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000288	0.00969	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000279	0.00938	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000278	0.00936	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—IL10—acquired immunodeficiency syndrome	0.000272	0.00915	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—CD40LG—acquired immunodeficiency syndrome	0.000272	0.00915	CbGpPWpGaD
Hydromorphone—OPRM1—IL4-mediated signaling events—IL4—acquired immunodeficiency syndrome	0.000265	0.0089	CbGpPWpGaD
Hydromorphone—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000255	0.0106	CbGeAlD
Hydromorphone—OPRK1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000253	0.0085	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000252	0.00849	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000252	0.00848	CbGpPWpGaD
Hydromorphone—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000251	0.0104	CbGeAlD
Hydromorphone—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000245	0.0102	CbGeAlD
Hydromorphone—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000241	0.01	CbGeAlD
Hydromorphone—OPRM1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000235	0.00791	CbGpPWpGaD
Hydromorphone—PTGS1—brain—acquired immunodeficiency syndrome	0.000233	0.00969	CbGeAlD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000233	0.00782	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000228	0.00768	CbGpPWpGaD
Hydromorphone—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000225	0.00936	CbGeAlD
Hydromorphone—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	0.000222	0.00747	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000221	0.00744	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000214	0.00718	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.00021	0.00707	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	0.000208	0.00698	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000204	0.00686	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.0002	0.00673	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—CD8A—acquired immunodeficiency syndrome	0.0002	0.00671	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000198	0.00665	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000198	0.00665	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000192	0.00646	CbGpPWpGaD
Hydromorphone—CYP2D6—brain—acquired immunodeficiency syndrome	0.000192	0.00796	CbGeAlD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000187	0.00629	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	0.000185	0.00621	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000184	0.0062	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—CCR5—acquired immunodeficiency syndrome	0.000183	0.00614	CbGpPWpGaD
Hydromorphone—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	0.000179	0.00603	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000177	0.00597	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000174	0.00585	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000173	0.00583	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000173	0.00583	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000172	0.00579	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000169	0.00569	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000169	0.00567	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000167	0.00561	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000167	0.00561	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000165	0.00554	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000163	0.00548	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000156	0.00524	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000156	0.00524	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000156	0.00523	CbGpPWpGaD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000155	0.0052	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000152	0.00513	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.00015	0.00506	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000148	0.00499	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000147	0.00493	CbGpPWpGaD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000147	0.00493	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000146	0.00492	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000146	0.00492	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000144	0.00485	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000143	0.0048	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000142	0.00479	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000141	0.00474	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000137	0.0046	CbGpPWpGaD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000136	0.00456	CbGpPWpGaD
Hydromorphone—OPRD1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000136	0.00456	CbGpPWpGaD
Hydromorphone—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	0.000134	0.00452	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000133	0.00446	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000133	0.00446	CbGpPWpGaD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000132	0.00443	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000131	0.00442	CbGpPWpGaD
Hydromorphone—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000488	CcSEcCtD
Hydromorphone—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000488	CcSEcCtD
Hydromorphone—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000488	CcSEcCtD
Hydromorphone—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.00013	0.000486	CcSEcCtD
Hydromorphone—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000486	CcSEcCtD
Hydromorphone—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000485	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000484	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000483	CcSEcCtD
Hydromorphone—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000129	0.000482	CcSEcCtD
Hydromorphone—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000482	CcSEcCtD
Hydromorphone—OPRM1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000129	0.00433	CbGpPWpGaD
Hydromorphone—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000482	CcSEcCtD
Hydromorphone—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000482	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000481	CcSEcCtD
Hydromorphone—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000481	CcSEcCtD
Hydromorphone—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000481	CcSEcCtD
Hydromorphone—Pain—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000478	CcSEcCtD
Hydromorphone—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000128	0.000478	CcSEcCtD
Hydromorphone—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000478	CcSEcCtD
Hydromorphone—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000128	0.000478	CcSEcCtD
Hydromorphone—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000478	CcSEcCtD
Hydromorphone—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000477	CcSEcCtD
Hydromorphone—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000476	CcSEcCtD
Hydromorphone—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000475	CcSEcCtD
Hydromorphone—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000475	CcSEcCtD
Hydromorphone—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000475	CcSEcCtD
Hydromorphone—OPRD1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000127	0.00427	CbGpPWpGaD
Hydromorphone—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000474	CcSEcCtD
Hydromorphone—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000474	CcSEcCtD
Hydromorphone—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000127	0.000473	CcSEcCtD
Hydromorphone—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000127	0.000473	CcSEcCtD
Hydromorphone—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000473	CcSEcCtD
Hydromorphone—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000472	CcSEcCtD
Hydromorphone—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000472	CcSEcCtD
Hydromorphone—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000471	CcSEcCtD
Hydromorphone—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000471	CcSEcCtD
Hydromorphone—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000471	CcSEcCtD
Hydromorphone—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.00047	CcSEcCtD
Hydromorphone—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000469	CcSEcCtD
Hydromorphone—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000469	CcSEcCtD
Hydromorphone—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000469	CcSEcCtD
Hydromorphone—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000468	CcSEcCtD
Hydromorphone—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000125	0.000466	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000466	CcSEcCtD
Hydromorphone—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000465	CcSEcCtD
Hydromorphone—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000464	CcSEcCtD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000124	0.00416	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000124	0.00416	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000124	0.00416	CbGpPWpGaD
Hydromorphone—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000462	CcSEcCtD
Hydromorphone—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000123	0.000461	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000461	CcSEcCtD
Hydromorphone—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.00046	CcSEcCtD
Hydromorphone—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000123	0.000459	CcSEcCtD
Hydromorphone—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000123	0.000459	CcSEcCtD
Hydromorphone—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000459	CcSEcCtD
Hydromorphone—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.000459	CcSEcCtD
Hydromorphone—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000458	CcSEcCtD
Hydromorphone—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000457	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000122	0.000457	CcSEcCtD
Hydromorphone—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000457	CcSEcCtD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000122	0.0041	CbGpPWpGaD
Hydromorphone—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000456	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000456	CcSEcCtD
Hydromorphone—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000456	CcSEcCtD
Hydromorphone—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000122	0.000456	CcSEcCtD
Hydromorphone—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000456	CcSEcCtD
Hydromorphone—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000454	CcSEcCtD
Hydromorphone—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000454	CcSEcCtD
Hydromorphone—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000454	CcSEcCtD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000121	0.00407	CbGpPWpGaD
Hydromorphone—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000452	CcSEcCtD
Hydromorphone—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000452	CcSEcCtD
Hydromorphone—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000452	CcSEcCtD
Hydromorphone—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000121	0.000452	CcSEcCtD
Hydromorphone—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000121	0.000451	CcSEcCtD
Hydromorphone—OPRM1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000121	0.00406	CbGpPWpGaD
Hydromorphone—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000451	CcSEcCtD
Hydromorphone—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000121	0.000451	CcSEcCtD
Hydromorphone—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000449	CcSEcCtD
Hydromorphone—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00012	0.000449	CcSEcCtD
Hydromorphone—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000448	CcSEcCtD
Hydromorphone—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000448	CcSEcCtD
Hydromorphone—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000448	CcSEcCtD
Hydromorphone—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.000447	CcSEcCtD
Hydromorphone—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000446	CcSEcCtD
Hydromorphone—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000446	CcSEcCtD
Hydromorphone—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000445	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000445	CcSEcCtD
Hydromorphone—OPRK1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000119	0.004	CbGpPWpGaD
Hydromorphone—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000119	0.000444	CcSEcCtD
Hydromorphone—OPRD1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000119	0.00399	CbGpPWpGaD
Hydromorphone—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000443	CcSEcCtD
Hydromorphone—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000442	CcSEcCtD
Hydromorphone—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000442	CcSEcCtD
Hydromorphone—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000118	0.000442	CcSEcCtD
Hydromorphone—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000441	CcSEcCtD
Hydromorphone—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000118	0.000441	CcSEcCtD
Hydromorphone—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000118	0.00044	CcSEcCtD
Hydromorphone—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000439	CcSEcCtD
Hydromorphone—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000438	CcSEcCtD
Hydromorphone—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000117	0.000438	CcSEcCtD
Hydromorphone—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000117	0.000437	CcSEcCtD
Hydromorphone—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000437	CcSEcCtD
Hydromorphone—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000437	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000436	CcSEcCtD
Hydromorphone—Rash—Stavudine—acquired immunodeficiency syndrome	0.000117	0.000436	CcSEcCtD
Hydromorphone—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000436	CcSEcCtD
Hydromorphone—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000117	0.000436	CcSEcCtD
Hydromorphone—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000435	CcSEcCtD
Hydromorphone—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000435	CcSEcCtD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000116	0.00391	CbGpPWpGaD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000116	0.00391	CbGpPWpGaD
Hydromorphone—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.000435	CcSEcCtD
Hydromorphone—Headache—Stavudine—acquired immunodeficiency syndrome	0.000116	0.000433	CcSEcCtD
Hydromorphone—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000116	0.000433	CcSEcCtD
Hydromorphone—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000433	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000116	0.00389	CbGpPWpGaD
Hydromorphone—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000432	CcSEcCtD
Hydromorphone—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000432	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000116	0.000432	CcSEcCtD
Hydromorphone—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000431	CcSEcCtD
Hydromorphone—Rash—Abacavir—acquired immunodeficiency syndrome	0.000115	0.00043	CcSEcCtD
Hydromorphone—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000115	0.000429	CcSEcCtD
Hydromorphone—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000429	CcSEcCtD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000115	0.00386	CbGpPWpGaD
Hydromorphone—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000429	CcSEcCtD
Hydromorphone—OPRM1—TCR Signaling Pathway—CD4—acquired immunodeficiency syndrome	0.000115	0.00386	CbGpPWpGaD
Hydromorphone—OPRD1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000114	0.00384	CbGpPWpGaD
Hydromorphone—Headache—Abacavir—acquired immunodeficiency syndrome	0.000114	0.000427	CcSEcCtD
Hydromorphone—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000426	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.000426	CcSEcCtD
Hydromorphone—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000114	0.000426	CcSEcCtD
Hydromorphone—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000114	0.000425	CcSEcCtD
Hydromorphone—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000423	CcSEcCtD
Hydromorphone—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000422	CcSEcCtD
Hydromorphone—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000421	CcSEcCtD
Hydromorphone—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00042	CcSEcCtD
Hydromorphone—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.00042	CcSEcCtD
Hydromorphone—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.00042	CcSEcCtD
Hydromorphone—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000418	CcSEcCtD
Hydromorphone—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000112	0.000418	CcSEcCtD
Hydromorphone—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000417	CcSEcCtD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000111	0.00375	CbGpPWpGaD
Hydromorphone—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000417	CcSEcCtD
Hydromorphone—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000417	CcSEcCtD
Hydromorphone—OPRK1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000111	0.00374	CbGpPWpGaD
Hydromorphone—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000416	CcSEcCtD
Hydromorphone—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000415	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000111	0.000413	CcSEcCtD
Hydromorphone—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.00011	0.00371	CbGpPWpGaD
Hydromorphone—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00011	0.000412	CcSEcCtD
Hydromorphone—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00011	0.000412	CcSEcCtD
Hydromorphone—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000411	CcSEcCtD
Hydromorphone—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000411	CcSEcCtD
Hydromorphone—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00011	0.000411	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.00041	CcSEcCtD
Hydromorphone—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000409	CcSEcCtD
Hydromorphone—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000407	CcSEcCtD
Hydromorphone—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000406	CcSEcCtD
Hydromorphone—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000405	CcSEcCtD
Hydromorphone—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000404	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000404	CcSEcCtD
Hydromorphone—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000403	CcSEcCtD
Hydromorphone—OPRD1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000107	0.00361	CbGpPWpGaD
Hydromorphone—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.000402	CcSEcCtD
Hydromorphone—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000401	CcSEcCtD
Hydromorphone—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000401	CcSEcCtD
Hydromorphone—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000401	CcSEcCtD
Hydromorphone—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.0004	CcSEcCtD
Hydromorphone—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.0004	CcSEcCtD
Hydromorphone—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.0004	CcSEcCtD
Hydromorphone—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.0004	CcSEcCtD
Hydromorphone—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000107	0.0004	CcSEcCtD
Hydromorphone—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000398	CcSEcCtD
Hydromorphone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	0.000106	0.00357	CbGpPWpGaD
Hydromorphone—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000396	CcSEcCtD
Hydromorphone—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000106	0.000396	CcSEcCtD
Hydromorphone—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000391	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000391	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000105	0.00351	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000104	0.0035	CbGpPWpGaD
Hydromorphone—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000389	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000388	CcSEcCtD
Hydromorphone—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000388	CcSEcCtD
Hydromorphone—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000388	CcSEcCtD
Hydromorphone—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Hydromorphone—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Hydromorphone—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Hydromorphone—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000385	CcSEcCtD
Hydromorphone—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000383	CcSEcCtD
Hydromorphone—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000383	CcSEcCtD
Hydromorphone—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000102	0.000382	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000382	CcSEcCtD
Hydromorphone—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000382	CcSEcCtD
Hydromorphone—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000379	CcSEcCtD
Hydromorphone—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000379	CcSEcCtD
Hydromorphone—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000379	CcSEcCtD
Hydromorphone—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000378	CcSEcCtD
Hydromorphone—OPRD1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000101	0.0034	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000101	0.0034	CbGpPWpGaD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000101	0.00339	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000101	0.00339	CbGpPWpGaD
Hydromorphone—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000101	0.000377	CcSEcCtD
Hydromorphone—OPRM1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.0001	0.00338	CbGpPWpGaD
Hydromorphone—OPRK1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.0001	0.00337	CbGpPWpGaD
Hydromorphone—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.0001	0.000374	CcSEcCtD
Hydromorphone—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	9.98e-05	0.000373	CcSEcCtD
Hydromorphone—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	9.96e-05	0.000372	CcSEcCtD
Hydromorphone—Urticaria—Ritonavir—acquired immunodeficiency syndrome	9.93e-05	0.000371	CcSEcCtD
Hydromorphone—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	9.91e-05	0.000371	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	9.91e-05	0.000371	CcSEcCtD
Hydromorphone—Fatigue—Lamivudine—acquired immunodeficiency syndrome	9.9e-05	0.00037	CcSEcCtD
Hydromorphone—Dizziness—Indinavir—acquired immunodeficiency syndrome	9.89e-05	0.00037	CcSEcCtD
Hydromorphone—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	9.88e-05	0.00037	CcSEcCtD
Hydromorphone—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	9.88e-05	0.00037	CcSEcCtD
Hydromorphone—OPRD1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	9.87e-05	0.00332	CbGpPWpGaD
Hydromorphone—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	9.84e-05	0.000368	CcSEcCtD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	9.83e-05	0.0033	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	9.83e-05	0.0033	CbGpPWpGaD
Hydromorphone—Constipation—Lamivudine—acquired immunodeficiency syndrome	9.82e-05	0.000367	CcSEcCtD
Hydromorphone—Pain—Lamivudine—acquired immunodeficiency syndrome	9.82e-05	0.000367	CcSEcCtD
Hydromorphone—Asthenia—Delavirdine—acquired immunodeficiency syndrome	9.7e-05	0.000363	CcSEcCtD
Hydromorphone—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	9.67e-05	0.000361	CcSEcCtD
Hydromorphone—OPRD1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	9.62e-05	0.00323	CbGpPWpGaD
Hydromorphone—Pruritus—Delavirdine—acquired immunodeficiency syndrome	9.56e-05	0.000358	CcSEcCtD
Hydromorphone—Urticaria—Saquinavir—acquired immunodeficiency syndrome	9.56e-05	0.000357	CcSEcCtD
Hydromorphone—Nausea—Zidovudine—acquired immunodeficiency syndrome	9.55e-05	0.000357	CcSEcCtD
Hydromorphone—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	9.51e-05	0.000356	CcSEcCtD
Hydromorphone—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	9.51e-05	0.000356	CcSEcCtD
Hydromorphone—Vomiting—Indinavir—acquired immunodeficiency syndrome	9.51e-05	0.000356	CcSEcCtD
Hydromorphone—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	9.46e-05	0.000354	CcSEcCtD
Hydromorphone—Rash—Indinavir—acquired immunodeficiency syndrome	9.43e-05	0.000353	CcSEcCtD
Hydromorphone—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.42e-05	0.000352	CcSEcCtD
Hydromorphone—OPRK1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.42e-05	0.00317	CbGpPWpGaD
Hydromorphone—OPRM1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	9.4e-05	0.00316	CbGpPWpGaD
Hydromorphone—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	9.39e-05	0.000351	CcSEcCtD
Hydromorphone—Headache—Indinavir—acquired immunodeficiency syndrome	9.37e-05	0.00035	CcSEcCtD
Hydromorphone—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.34e-05	0.000349	CcSEcCtD
Hydromorphone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	9.3e-05	0.00313	CbGpPWpGaD
Hydromorphone—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.25e-05	0.000346	CcSEcCtD
Hydromorphone—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	9.21e-05	0.000344	CcSEcCtD
Hydromorphone—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.12e-05	0.000341	CcSEcCtD
Hydromorphone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	9.09e-05	0.00306	CbGpPWpGaD
Hydromorphone—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.07e-05	0.000339	CcSEcCtD
Hydromorphone—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.07e-05	0.000339	CcSEcCtD
Hydromorphone—Vomiting—Efavirenz—acquired immunodeficiency syndrome	8.98e-05	0.000336	CcSEcCtD
Hydromorphone—Asthenia—Ritonavir—acquired immunodeficiency syndrome	8.97e-05	0.000335	CcSEcCtD
Hydromorphone—Dizziness—Delavirdine—acquired immunodeficiency syndrome	8.94e-05	0.000334	CcSEcCtD
Hydromorphone—OPRD1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	8.92e-05	0.003	CbGpPWpGaD
Hydromorphone—Rash—Efavirenz—acquired immunodeficiency syndrome	8.91e-05	0.000333	CcSEcCtD
Hydromorphone—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	8.9e-05	0.000333	CcSEcCtD
Hydromorphone—Nausea—Indinavir—acquired immunodeficiency syndrome	8.88e-05	0.000332	CcSEcCtD
Hydromorphone—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	8.86e-05	0.000331	CcSEcCtD
Hydromorphone—OPRK1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.86e-05	0.00298	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.86e-05	0.00298	CbGpPWpGaD
Hydromorphone—Headache—Efavirenz—acquired immunodeficiency syndrome	8.85e-05	0.000331	CcSEcCtD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.85e-05	0.00297	CbGpPWpGaD
Hydromorphone—Pruritus—Ritonavir—acquired immunodeficiency syndrome	8.84e-05	0.000331	CcSEcCtD
Hydromorphone—OPRM1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	8.8e-05	0.00296	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	8.65e-05	0.00291	CbGpPWpGaD
Hydromorphone—Asthenia—Saquinavir—acquired immunodeficiency syndrome	8.63e-05	0.000323	CcSEcCtD
Hydromorphone—Vomiting—Delavirdine—acquired immunodeficiency syndrome	8.59e-05	0.000321	CcSEcCtD
Hydromorphone—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.55e-05	0.00032	CcSEcCtD
Hydromorphone—Rash—Delavirdine—acquired immunodeficiency syndrome	8.52e-05	0.000319	CcSEcCtD
Hydromorphone—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.52e-05	0.000318	CcSEcCtD
Hydromorphone—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.51e-05	0.000318	CcSEcCtD
Hydromorphone—OPRM1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	8.47e-05	0.00285	CbGpPWpGaD
Hydromorphone—Headache—Delavirdine—acquired immunodeficiency syndrome	8.47e-05	0.000317	CcSEcCtD
Hydromorphone—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	8.46e-05	0.000316	CcSEcCtD
Hydromorphone—OPRK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.44e-05	0.00284	CbGpPWpGaD
Hydromorphone—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.39e-05	0.000314	CcSEcCtD
Hydromorphone—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.27e-05	0.000309	CcSEcCtD
Hydromorphone—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.23e-05	0.000308	CcSEcCtD
Hydromorphone—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.23e-05	0.000308	CcSEcCtD
Hydromorphone—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.12e-05	0.000304	CcSEcCtD
Hydromorphone—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.03e-05	0.0003	CcSEcCtD
Hydromorphone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.97e-05	0.00268	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	7.96e-05	0.00268	CbGpPWpGaD
Hydromorphone—Dizziness—Saquinavir—acquired immunodeficiency syndrome	7.96e-05	0.000298	CcSEcCtD
Hydromorphone—Vomiting—Ritonavir—acquired immunodeficiency syndrome	7.95e-05	0.000297	CcSEcCtD
Hydromorphone—Rash—Ritonavir—acquired immunodeficiency syndrome	7.88e-05	0.000295	CcSEcCtD
Hydromorphone—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	7.87e-05	0.000294	CcSEcCtD
Hydromorphone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	7.86e-05	0.00264	CbGpPWpGaD
Hydromorphone—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.000294	CcSEcCtD
Hydromorphone—Headache—Ritonavir—acquired immunodeficiency syndrome	7.83e-05	0.000293	CcSEcCtD
Hydromorphone—OPRK1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.82e-05	0.00263	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—TAT—acquired immunodeficiency syndrome	7.77e-05	0.00261	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	7.68e-05	0.00258	CbGpPWpGaD
Hydromorphone—Vomiting—Saquinavir—acquired immunodeficiency syndrome	7.65e-05	0.000286	CcSEcCtD
Hydromorphone—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000284	CcSEcCtD
Hydromorphone—Rash—Saquinavir—acquired immunodeficiency syndrome	7.59e-05	0.000284	CcSEcCtD
Hydromorphone—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.58e-05	0.000283	CcSEcCtD
Hydromorphone—Headache—Saquinavir—acquired immunodeficiency syndrome	7.54e-05	0.000282	CcSEcCtD
Hydromorphone—OPRM1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	7.48e-05	0.00252	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	7.48e-05	0.00252	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	7.48e-05	0.00251	CbGpPWpGaD
Hydromorphone—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.42e-05	0.000278	CcSEcCtD
Hydromorphone—OPRM1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.31e-05	0.00246	CbGpPWpGaD
Hydromorphone—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.3e-05	0.000273	CcSEcCtD
Hydromorphone—Rash—Lamivudine—acquired immunodeficiency syndrome	7.24e-05	0.000271	CcSEcCtD
Hydromorphone—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.23e-05	0.00027	CcSEcCtD
Hydromorphone—Headache—Lamivudine—acquired immunodeficiency syndrome	7.19e-05	0.000269	CcSEcCtD
Hydromorphone—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000267	CcSEcCtD
Hydromorphone—OPRM1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.13e-05	0.0024	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.92e-05	0.00233	CbGpPWpGaD
Hydromorphone—Nausea—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000255	CcSEcCtD
Hydromorphone—OPRK1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.74e-05	0.00227	CbGpPWpGaD
Hydromorphone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	6.74e-05	0.00227	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.61e-05	0.00222	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—AGPS—acquired immunodeficiency syndrome	6.61e-05	0.00222	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	6.52e-05	0.00219	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.36e-05	0.00214	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	6.34e-05	0.00213	CbGpPWpGaD
Hydromorphone—OPRM1—TCR Signaling Pathway—IL6—acquired immunodeficiency syndrome	6.2e-05	0.00208	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	6.1e-05	0.00205	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	6.07e-05	0.00204	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.07e-05	0.00204	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.83e-05	0.00196	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.83e-05	0.00196	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.71e-05	0.00192	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.71e-05	0.00192	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	5.69e-05	0.00191	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.51e-05	0.00185	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.39e-05	0.00181	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.34e-05	0.0018	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.32e-05	0.00179	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.27e-05	0.00177	CbGpPWpGaD
Hydromorphone—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	5.26e-05	0.00177	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	5.18e-05	0.00174	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	5.18e-05	0.00174	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.13e-05	0.00172	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.11e-05	0.00172	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.11e-05	0.00172	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5e-05	0.00168	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5e-05	0.00168	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.83e-05	0.00163	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.62e-05	0.00155	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.54e-05	0.00153	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.54e-05	0.00153	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.52e-05	0.00152	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.5e-05	0.00151	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4.34e-05	0.00146	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.32e-05	0.00145	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.32e-05	0.00145	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	4.28e-05	0.00144	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.23e-05	0.00142	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.23e-05	0.00142	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.09e-05	0.00137	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.94e-05	0.00133	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.91e-05	0.00132	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.91e-05	0.00131	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.88e-05	0.00131	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.84e-05	0.00129	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.84e-05	0.00129	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.81e-05	0.00128	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.75e-05	0.00126	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.6e-05	0.00121	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.55e-05	0.00119	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.46e-05	0.00116	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.43e-05	0.00115	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.41e-05	0.00115	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	3.36e-05	0.00113	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	3.33e-05	0.00112	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.26e-05	0.00109	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.22e-05	0.00108	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.17e-05	0.00107	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.16e-05	0.00106	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.11e-05	0.00105	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.06e-05	0.00103	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.06e-05	0.00103	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.04e-05	0.00102	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.92e-05	0.000983	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.9e-05	0.000975	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.88e-05	0.000968	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.86e-05	0.00096	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.86e-05	0.00096	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	2.83e-05	0.000952	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.68e-05	0.000903	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.68e-05	0.000903	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.67e-05	0.000897	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.63e-05	0.000885	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.48e-05	0.000834	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.41e-05	0.000811	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.33e-05	0.000783	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.29e-05	0.000771	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.27e-05	0.000763	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.27e-05	0.000763	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.26e-05	0.00076	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.2e-05	0.000739	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.1e-05	0.000706	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	2.05e-05	0.00069	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.04e-05	0.000687	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.01e-05	0.000676	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.98e-05	0.000666	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.87e-05	0.000628	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.84e-05	0.000619	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.8e-05	0.000605	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.73e-05	0.00058	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.7e-05	0.000572	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.67e-05	0.000563	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.56e-05	0.000523	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.52e-05	0.000511	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALB—acquired immunodeficiency syndrome	1.36e-05	0.000456	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.3e-05	0.000438	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000408	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.21e-05	0.000406	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	1.1e-05	0.000371	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000357	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.06e-05	0.000356	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.99e-06	0.000302	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.94e-06	0.000301	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.13e-06	0.00024	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.25e-06	0.00021	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	5.86e-06	0.000197	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	5.81e-06	0.000195	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.28e-06	0.000178	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	3.83e-06	0.000129	CbGpPWpGaD
